卡托普利治疗急性心肌梗塞合并心房颤动的临床观察  

Captoplil treatment for patient with acute myocardial infarction complicated atrial fibrillation

作　　者：陈自力[1] 杨飞[1] 郑继平[1] 陈长弓 赵旭[1] 

机构地区：[1]浙江省台州市第一人民医院,浙江台州318020

出　　处：《心血管康复医学杂志》2006年第4期371-372,共2页Chinese Journal of Cardiovascular Rehabilitation Medicine

摘　　要：目的:观察卡托普利在急性心肌梗塞(AMI)合并心房颤动治疗中的作用。方法:比较AMI合并心房颤动卡托普利治疗组和非卡托普利治疗组(对照组)的阵发性心房颤动(PAF)再发率,转为持续性或永久性心房颤动的发生率,以及缺血相关事件发生率。结果:AMI合并心房颤动卡托普利治疗组PAF再发率(12.5%),转为持续性或永久性心房颤动的发生率(6.2%),以及缺血相关事件发生率(25%)明显低于对照组(25.8%,16.1%,41.9%,P<0.05)。结论:卡托普利治疗急性心肌梗塞合并心房颤动减少了心房颤动的复发率,并减少其缺血事件的发生率。Objective： To study the significance of captoplil treatment on patient with acute myocardial infarction （AMI） complicated atrial fibrillation. Methods： A total of 63 AMI patients complicated atrial fibrillation were randomly divided into captoplil treatment group （32 cases） and control group （without captoplil treatment, 31 cases）. Results ： Recurrence rate of paroxysmal atrial fibrillation （12.5%）, incidence rate transformed persistence atrial fibrillation （6.2%）, and incidence rate of event correlated ischemia （25%） in captoplil treatment group were significantly less than those of control group （P〈0. 05）. Conclusion： Captoplil can decrease recurrence rate of paroxysmal atrial fibrillation and incidence rate of event correlated ischemia in AMI patient complicated atrial fibrillation.

关 键 词：心肌梗塞 心房颤动 卡托普利 治疗 

分 类 号：R542.22[医药卫生—心血管疾病]